Merck Animal Health Acquires Elanco’s Aqua Business

Platinum Equity Acquires Lonza's Water Care Business

February 28, 2019

Manufacturing

Platinum Equity completed the acquisition of Lonza's water care business in a transaction valued at approximately $630 million. Headquartered in Alpharetta, Georgia, the business operates six production facilities across North America, South America and EMEA and supplies consumer pool-care brands and industrial/municipal water treatment solutions; Platinum Equity will operate it as a standalone platform and will announce a new corporate identity.

Elanco Animal Health to Acquire Kindred Biosciences

June 16, 2021

Healthcare Services

Elanco Animal Health Incorporated entered into a definitive agreement to acquire Kindred Biosciences for $9.25 per share, or approximately $440 million. The acquisition expands Elanco’s presence in pet health—especially dermatology—by adding a pipeline of monoclonal antibody biologics and related R&D capabilities.

Elanco Animal Health Acquires Aratana Therapeutics

July 18, 2019

Pharmaceuticals

Elanco Animal Health Incorporated completed its acquisition of Aratana Therapeutics, a developer and commercializer of specialty therapeutics for dogs and cats, including Galliprant, Entyce and Nocita. The deal expands Elanco's companion animal product portfolio and establishes a dedicated specialty veterinary commercial team to integrate Aratana's field force and pipeline.

Evoqua Water Technologies Acquires Renal Business from STERIS (Mar Cor / Cantel Operations)

January 3, 2022

Industrial Services

Evoqua Water Technologies has closed the acquisition of the renal business historically operated by Mar Cor Purification and Cantel Medical, subsidiaries of STERIS Plc. The acquired business, expected to generate approximately $180 million of annualized revenue and $27 million of adjusted EBITDA (pre-synergies), expands Evoqua’s service footprint in North America and furthers its reach into the healthcare vertical.

Xylem Acquires Evoqua in $7.5 Billion All-Stock Transaction

May 24, 2023

Healthcare Services

Xylem (NYSE: XYL) completed its acquisition of Evoqua Water Technologies Corp. (NYSE: AQUA) in an all-stock transaction valued at approximately $7.5 billion. The deal combines Xylem’s water technology portfolio with Evoqua’s mission-critical water treatment solutions and services to create a scaled global platform serving utilities and industrial/commercial end markets.

Merck Animal Health Acquires Vence

September 22, 2022

AI & Machine Learning

Merck Animal Health (a division of Merck & Co., Inc.) signed a definitive agreement to acquire Vence from its founders and shareholders. The acquisition will expand Merck Animal Health’s animal intelligence and virtual fencing technology portfolio for cattle producers and ranchers, and is expected to close in Q3 2022 subject to customary conditions.